Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Neurodegenerative diseases (NDs) are a heterogeneous group of disorders affecting the central nervous system. Despite significant differences in their causes, neuropathological abnormalities, and clinical outcomes, some similarities can be found among them, as for example: 1) frequent aggregation and deposition of misfolded proteins, 2) common molecular mechanisms leading to neurodegeneration, and 3) certain overlap in symptoms and clinical features. To date, there is no cure that could stop or delay the progression of these diseases. The advent of advanced gene therapy techniques such as gene silencing and gene editing opened a new avenue for the development of therapeutic strategies for NDs. The discovery of the RNA interference (RNAi) mechanism, in 1998, by Andrew Fire and Craig Mello allowed an important boost to the gene therapy field, providing a potential therapeutic strategy to treat inherited dominant genetic disorders. The use of small RNA sequences to control the expression of disease-causing genes rapidly implemented in the preclinical studies for different diseases. In the field of NDs, several successful studies using this technology proved its potential as a therapeutic option. However, issues like the type of delivery system (non-viral versus viral) or the potential toxicity of the small RNA molecules, made the translation of gene silencing therapeutics to human application very slow and difficult. Recently, a new hope in the gene therapy field emerged with the development of gene editing techniques like TALENs or CRISPR/Cas9 systems. The opportunity of editing or deleting gene sequences drove the scientific community euphoric, with an enormous increase in the number of published studies using this type of techniques. Recently, the first clinical trial using one of these systems was approved in China. For NDs, gene-editing technology also represents an important therapeutic option, and the first preclinical studies are now being published, showing the potential accomplishment for this technology.

Gene silencing --- Long non-coding RNAs --- RNA interference --- Neurodegenerative diseases --- CRISPR/Cas9 --- Neurodegeneration --- Gene editing --- Antisense oligonucleotides --- Neuroinflammation --- iPS cells

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Neurodegenerative diseases (NDs) are a heterogeneous group of disorders affecting the central nervous system. Despite significant differences in their causes, neuropathological abnormalities, and clinical outcomes, some similarities can be found among them, as for example: 1) frequent aggregation and deposition of misfolded proteins, 2) common molecular mechanisms leading to neurodegeneration, and 3) certain overlap in symptoms and clinical features. To date, there is no cure that could stop or delay the progression of these diseases. The advent of advanced gene therapy techniques such as gene silencing and gene editing opened a new avenue for the development of therapeutic strategies for NDs. The discovery of the RNA interference (RNAi) mechanism, in 1998, by Andrew Fire and Craig Mello allowed an important boost to the gene therapy field, providing a potential therapeutic strategy to treat inherited dominant genetic disorders. The use of small RNA sequences to control the expression of disease-causing genes rapidly implemented in the preclinical studies for different diseases. In the field of NDs, several successful studies using this technology proved its potential as a therapeutic option. However, issues like the type of delivery system (non-viral versus viral) or the potential toxicity of the small RNA molecules, made the translation of gene silencing therapeutics to human application very slow and difficult. Recently, a new hope in the gene therapy field emerged with the development of gene editing techniques like TALENs or CRISPR/Cas9 systems. The opportunity of editing or deleting gene sequences drove the scientific community euphoric, with an enormous increase in the number of published studies using this type of techniques. Recently, the first clinical trial using one of these systems was approved in China. For NDs, gene-editing technology also represents an important therapeutic option, and the first preclinical studies are now being published, showing the potential accomplishment for this technology.

Gene silencing --- Long non-coding RNAs --- RNA interference --- Neurodegenerative diseases --- CRISPR/Cas9 --- Neurodegeneration --- Gene editing --- Antisense oligonucleotides --- Neuroinflammation --- iPS cells

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact

Science: general issues --- Botany & plant sciences --- posttranscriptional regulation --- RNA processing --- RNA Stability --- RNA structure --- Alternative Splicing --- small RNAs --- MicroRNAs --- long non-coding RNAs --- tran

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book is a collection of eight articles, of which seven are reviews and one is a research paper, that together form a Special Issue that describes the roles that long noncoding RNAs (lncRNA) play in gene regulation at a post-transcriptional level.

long non-coding RNA 1 --- RNA binding protein 2 --- post-transcriptional regulation --- long non-coding RNA --- mRNA stability --- RNA binding protein --- microRNA --- gene expression --- long noncoding RNA --- target mimicry --- alternative splicing --- protein re-localization --- translation promotion --- post-translational modification --- double-stranded RNA (dsRNA) --- innate immunity --- repetitive DNA elements (RE) --- antisense transcript --- non-coding RNAs --- long non-coding RNAs --- ncRNAs --- translation --- cancer --- lncRNA --- post-transcription --- RNA-binding --- ribonucleoprotein --- RNAi --- interactome --- prediction --- database --- CLIP --- splicing factors --- miRNAs --- lncRNAs --- ceRNAs --- mTOR pathway --- n/a

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This Special Issue on ‘Advances in Cereal Crops Breeding’ comprises 10 papers covering a wide range of subjects, including the expression-level investigation of genes in terms of salinity stress adaptations and their relationships with proteomics in rice, the use of genetic analysis to assess the general combining ability (GCA) and specific combining ability (SCA) in promising hybrids of maize, the use of DNA markers based on PCR in rice, the identification of quantitative trait loci (QTLs) in wheat and simple sequence repeats (SSR) in rice, the use of single-nucleotide polymorphisms (SNP) in a genome-wide association study (GWAS) in cereals, and Nanopore direct RNA sequencing of related with LTR RNA retrotransposon in triticale prior to the genomic selection of heterotic maize hybrids.

Research & information: general --- maize --- density tolerance --- combining ability --- gene effects --- genetic diversity --- rice --- salinity --- submergence tolerance --- blast --- SSR markers --- PCR analysis --- long non-coding RNAs --- seed development --- Nanopore sequencing --- retrotransposons --- triticale --- prediction accuracy --- mixed linear and Bayesian models --- machine learning algorithms --- training set size and composition --- parametric and nonparametric models --- drought stress --- dendrogram --- barley --- breeding --- marker-assisted selection --- genes --- genetic resources --- genome editing --- health benefits --- metabolomics --- oat --- QTL --- wheat --- Triticum aestivum L. --- QMrl-7B --- root traits --- grain yield --- nitrogen use efficiency --- GWAS --- salinity tolerance --- Vietnamese landraces --- abiotic stress --- root --- auxin --- YUCCA --- PIN --- proteomics --- mass spectrometry --- n/a